Rights and permissions
About this article
Cite this article
Long-acting risperidone a cost-effective choice in Taiwan. Pharmacoecon. Outcomes News 487, 9 (2005). https://doi.org/10.2165/00151234-200504870-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504870-00023